Acute Anthracycline Induced Cardiotoxicity in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation

Anthracyclines remain the cornerstone of therapy for a wide spectrum of malignancies and have markedly improved survival of patients with acute myeloid leukemia (AML). There is scarce data regarding the acute cardiotoxic effects of anthracyclines in AML patients.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Oren Pasvolsky, Olga Morelli, Uri Rozovski, Moti Vaturi, Ofir Wolach, Irina Amitai, Iuliana Vaxman, Roy Ratzon, Moshe Yeshurun, Zaza Iakobishvilli, Ran Kornowski, Pia Raanani Source Type: research